 | Edwin CHAN Shih Yen BVMS (Hons), PhD Director, Cochrane Singapore Chief Scientific Officer, Singapore Clinical Research Institute Associate Professor, Duke-NUS Medical School |
 | Luming SHI MBBS, MSc (Clinical Sciences) MSc (Health Economics & Pharmacoeconomics) Deputy Director, Cochrane Singapore Scientific Director, Singapore Clinical Research Institute Adjunct Assistant Professor, Duke-NUS Medical School |
 | GUO Liang MBBS, MPH Staff member, Cochrane Singapore Head of HEOR, Singapore Clinical Research Institute |
 | Julie ZHU Yanan BSc, MSc, PhD (Pharmacology) Staff member, Cochrane Singapore Senior Epidemiologist, Singapore Clinical Research Institute |
 | CHAI Jia Hui BSc, MPH Staff member, Cochrane Singapore Health Economist, Singapore Clinical Research Institute |
 | Zaw Myo Tun MBBS, PhD Staff member, Cochrane Singapore Senior Epidemiologist, Singapore Clinical Research Institute |
 | Brendon Zhou Huijun MBBS, PhD Staff member, Cochrane Singapore Senior Economist, Singapore Clinical Research Institute |
 | Charles ZHENG Qishi MBBS, MPH, MSc (Health Economics & Pharmacoeconomics) Staff member, Cochrane Singapore |
 | Yoko WONG Kin Yoke BSc (Biology), MMedSci (Public Health), PhD (GAME) Staff member, Cochrane Singapore |
 | Fahad Javaid Siddiqui MBBS, MSc (Epidemiology and Biostatistics), MSc (Public Health) Staff member, Cochrane Singapore Assistant Professor, Duke-NUS Medical School Consultant, GUIDE Guideline Development Group, Canada Editor, Campbell Collaboration, United Kingdom |
Updated on 15 May 2025